Net Loss Per Share Attributable to Common Stockholders (Tables)

3 Months Ended

May 31, 2022

Net income (Loss) Per Share Attributable to Common Stockholders

Schedule of computation of basic and diluted net loss per share

	Three months ended
	May 31,
	2022		2021
Net loss	$	(342,822)	$	(48,707)
Weighted-average common shares used in computing net loss per share		69,738,638		58,261,233
Net loss per share attributable to common stockholders, basic and diluted	$	(4.92)	$	(0.84)

Schedule of common stock were excluded from the computation of diluted net loss per share attributable to common stockholders

	Three months ended
	May 31,
	2022	2021
Stock options	8,238,444	8,448,011
Unvested restricted stock units	2,579,247	501,952
Shares issued to 2nd.MD employees and subject to vesting	274,224	608,332
Contingent shares in connection with 2nd.MD acquisition	—	1,889,441
Shares issued to PlushCare employees and subject to vesting	831,398	—
Indemnity shares held in escrow in connection with PlushCare acquisition	27,342	—
Shares to be issued to HealthReveal shareholders upon expiration of indemnification	28,089	—
Convertible Senior Notes	5,700,297	5,700,297
Total	17,679,041	17,148,033